Polymorphism within the tumor necrosis factor α (TNF) promoter region in patients with ankylosing spondylitis

被引:43
作者
Kaijzel, EL [1 ]
Brinkman, BMN [1 ]
van Krugten, MV [1 ]
Smith, L [1 ]
Huizinga, TWJ [1 ]
Verjans, GMGM [1 ]
Breedveld, FC [1 ]
Verweij, CL [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands
关键词
tumor necrosis factor alpha; gene polymorphism; ankylosing spondylitis; HLA-B27;
D O I
10.1016/S0198-8859(98)00099-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to HLA-B27, other genetic factors are thought to be involved in the pathogenesis of ankylosing spondylitis (AS). Because of the location of the TNF gene in the vicinity of the HLA-B locus, and the prominent role in inflammation of its produce, we investigated the association between BS and two G to A transition polymorphisms located at position -238 and -376 in the promoter region of the TNF gene. The distribution of the TNF alleles was determined in 86 HLA-B27+ AS patients and 163 healthy controls. From the 86 AS patients, 33 suffered from acute anterior uveitis (AAU). No significant difference for the TNF-376 polymorphism in AS and healthy controls was observed. The frequency of the TNF-238A allele in HLA-B27(+) AS patients was significantly decreased compared to random controls (p = 0.021). However, the frequency of the TNF-238A allele in HLA-B27(+) AS patients was not significantly different from chat observed in HLA-B27(+) healthy individuals (p = 0.6). Assessment of association showed that the TNF-238G allele is in linkage disequilibrium with the HLA-B27 allele (Delta = 0.051; P = 0.008). Therefore, we conclude that the association between TNF-238G and AS is secondary to the HLA-B27 gene and that TNF-238 and TNF-376 alleles are nor likely to be involved in the susceptibility to AS. Human Immunology 60, 140-144 (1999). (C) American Society for Histocompatibility and Immunogenetics, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 32 条
[1]  
BREWERTON D, 1990, LANCET, V335, P904
[2]  
Brinkman BMN, 1996, J INFLAMM, V46, P32
[3]  
Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516
[4]  
Brown Matthew, 1997, Current Opinion in Rheumatology, V9, P308
[5]   POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS [J].
CABRERA, M ;
SHAW, MA ;
SHARPLES, C ;
WILLIAMS, H ;
CASTES, M ;
CONVIT, J ;
BLACKWELL, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1259-1264
[6]   MAP OF THE HUMAN MHC [J].
CAMPBELL, RD ;
TROWSDALE, J .
IMMUNOLOGY TODAY, 1993, 14 (07) :349-352
[7]   Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid [J].
Conway, DJ ;
Holland, MJ ;
Bailey, RL ;
Campbell, AE ;
Mahdi, OSM ;
Jennings, R ;
Mbena, E ;
Mabey, DCW .
INFECTION AND IMMUNITY, 1997, 65 (03) :1003-1006
[8]  
DALFONSO S, 1994, IMMUNOGENETICS, V39, P150
[9]   Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population [J].
DAlfonso, S ;
Colombo, G ;
Della Bella, S ;
Scorza, R ;
MomiglianoRichiardi, P .
TISSUE ANTIGENS, 1996, 47 (06) :551-555
[10]  
Fleiss JL, 1981, STAT METHODS RATES P